ConductScience.org, home

Paper42792016PubMed

Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center.

Radu VD and 14 others. Antibiotics (Basel), 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center. Papers, record 42792016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42792016

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center.
Journal
Antibiotics (Basel)
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-09-29

Source PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Radu VDViorel Dragoshttps://orcid.org/0009-0008-2065-2926
2Pauna ARAna-Maria Ralucahttps://orcid.org/0000-0001-6304-9950
3Radu RRodicahttps://orcid.org/0000-0001-5335-7909
4Mititelu-Tartau LLilianahttps://orcid.org/0000-0001-7983-3811
5Vasilescu AMAlin Mihaihttps://orcid.org/0000-0002-9865-5114
6Pantilimonescu TFTheodor Florinhttps://orcid.org/0009-0004-5860-3696
7Grigoraș AAdrianahttps://orcid.org/0000-0001-6641-5135
8Florea LLaura
9Moraru MCMarius Constantinhttps://orcid.org/0009-0008-5292-7971
10Chelaru LLiliana
11Gavril LCLiviu Ciprian
12Gavril RFRoxana Florentina
13Buca BRBeatrice Rozalinahttps://orcid.org/0000-0002-0693-5478
14Koush AAAngy Abuhttps://orcid.org/0009-0002-2015-7032
15Mititiuc ILIrina Luanda

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,533,669Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis.Eur J Transl Myol2022https://conductscience.org/library/papers/36533669PubMed
236,857,834A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic.J Infect Public Health2023https://conductscience.org/library/papers/36857834PubMed
333,276,108Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury.Pharmacol Res2021https://conductscience.org/library/papers/33276108PubMed
440,245,910The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance.Lancet Infect Dis2025https://conductscience.org/library/papers/40245910PubMed
539,081,869Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/39081869PubMed
636,774,938Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.Lancet Microbe2023https://conductscience.org/library/papers/36774938PubMed
738,183,224Reviewing novel treatment options for carbapenem-resistant Enterobacterales.Expert Rev Anti Infect Ther2024https://conductscience.org/library/papers/38183224PubMed
835,255,988Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).Antimicrob Resist Infect Control2022https://conductscience.org/library/papers/35255988PubMed
941,201,487Nephrotoxicity of polymyxin B and colistin sulfate in patients with multidrug-resistant gram-negative bacteria infections: a parametric time-to-event analysis.Int J Clin Pharm2026https://conductscience.org/library/papers/41201487PubMed
1035,781,159Effects of Bacterial Urinary Tract Infection on Clinical Outcome and Survival of Kidney Transplant Patients.Transplant Proc2022https://conductscience.org/library/papers/35781159PubMed
1141,011,759Emergence of Carbapenem-Resistant Klebsiella pneumoniae in a Romanian Infectious Diseases Hospital.Pathogens2025https://conductscience.org/library/papers/41011759PubMed
1232,781,593Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia.Antibiotics (Basel)2020https://conductscience.org/library/papers/32781593PubMed
1341,009,897Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance.Antibiotics (Basel)2025https://conductscience.org/library/papers/41009897PubMed
1436,009,935The Effect of Different Colistin Dosing Regimens on Nephrotoxicity: A Cohort Study.Antibiotics (Basel)2022https://conductscience.org/library/papers/36009935PubMed
1542,112,222Antimicrobial resistance trends during COVID-19 in male patients: a descriptive analysis.J Med Life2026https://conductscience.org/library/papers/42112222PubMed
1626,903,338The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA2016https://conductscience.org/library/papers/26903338PubMed
1735,065,702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed
1836,088,407Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections.Sci Rep2022https://conductscience.org/library/papers/36088407PubMed
1939,299,261Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.Lancet2024https://conductscience.org/library/papers/39299261PubMed
2036,388,829Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study.Ann Transl Med2022https://conductscience.org/library/papers/36388829PubMed

See all 43 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42792016

GET https://conductscience.org/api/papers/v1/42792016/references?page=2